These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharmacokinetic of antibiotics in patients with mucoviscidosis (author's transl)]. Guggenbichler JP; Pillwein K; Schabel F; Rohrer R Padiatr Padol; 1981; 16(4):393-402. PubMed ID: 7301388 [TBL] [Abstract][Full Text] [Related]
3. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin. Parry MF; Neu HC; Merlino M; Gaerlan PF; Ores CN; Denning CR J Pediatr; 1977 Jan; 90(1):144-8. PubMed ID: 401521 [TBL] [Abstract][Full Text] [Related]
4. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407 [TBL] [Abstract][Full Text] [Related]
5. Azlocillin in cystic fibrosis. Malmborg AS; Alfredsson H; Strandvik B Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681 [TBL] [Abstract][Full Text] [Related]
6. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis]. Grenier B; Gilly R Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin. Schaad UB; Desgrandchamps D; Kraemer R Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120 [TBL] [Abstract][Full Text] [Related]
9. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis. Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788 [TBL] [Abstract][Full Text] [Related]
10. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis. Michalsen H; Bergan T Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708 [TBL] [Abstract][Full Text] [Related]
11. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis. Parry MF; Neu HC J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276 [TBL] [Abstract][Full Text] [Related]
12. Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis. Penketh AR; Hodson ME; Batten JC Br J Dis Chest; 1983 Apr; 77(2):179-84. PubMed ID: 6871085 [TBL] [Abstract][Full Text] [Related]
13. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group. Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118 [TBL] [Abstract][Full Text] [Related]
14. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis. Penketh A; Hodson ME; Gaya H; Batten JC Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075 [TBL] [Abstract][Full Text] [Related]
15. Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients. Vic P; Ategbo S; Turck D; Husson MO; Tassin E; Loeuille GA; Deschildre A; Druon D; Elian JC; Arrouet-Lagandre C; Farriaux JP Eur J Pediatr; 1996 Nov; 155(11):948-53. PubMed ID: 8911895 [TBL] [Abstract][Full Text] [Related]
16. Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. Marks MI; Prentice R; Swarson R; Cotton EK; Eickhoff TC J Pediatr; 1971 Nov; 79(5):822-8. PubMed ID: 5000612 [No Abstract] [Full Text] [Related]
17. Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosis. Jackson MA; Kusmiesz H; Shelton S; Prestidge C; Kramer RI; Nelson JD Pediatr Infect Dis; 1986; 5(4):440-3. PubMed ID: 3725655 [TBL] [Abstract][Full Text] [Related]
18. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin. Conway SP; Miller MG; Ramsden C; Littlewood JM Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. Møller NE; Høiby N Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884 [TBL] [Abstract][Full Text] [Related]
20. Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study. Crowther Labiris NR; Holbrook AM; Chrystyn H; Macleod SM; Newhouse MT Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1711-6. PubMed ID: 10556145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]